WO2009019616A3 - Isoprekinamycin analogs and syntheses thereof - Google Patents
Isoprekinamycin analogs and syntheses thereof Download PDFInfo
- Publication number
- WO2009019616A3 WO2009019616A3 PCT/IB2008/003117 IB2008003117W WO2009019616A3 WO 2009019616 A3 WO2009019616 A3 WO 2009019616A3 IB 2008003117 W IB2008003117 W IB 2008003117W WO 2009019616 A3 WO2009019616 A3 WO 2009019616A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- isoprekinamycin
- syntheses
- analogs
- present
- natural products
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/12—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/30—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a six-membered aromatic ring being part of a condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/86—Ring systems containing bridged rings containing four rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to the preparation of various benzo[α]fluorenes The benzo[α]fluorene moiety appears in a variety of natural products, some of which have been shown to exhibit anticancer and antibacterial effects Methods of the present invention provide facile access to some of these natural products as well as derivatives thereof.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95480607P | 2007-08-08 | 2007-08-08 | |
US60/954,806 | 2007-08-08 | ||
US95518707P | 2007-08-10 | 2007-08-10 | |
US60/955,187 | 2007-08-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009019616A2 WO2009019616A2 (en) | 2009-02-12 |
WO2009019616A3 true WO2009019616A3 (en) | 2011-04-28 |
Family
ID=40341835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2008/003117 WO2009019616A2 (en) | 2007-08-08 | 2008-08-08 | Isoprekinamycin analogs and syntheses thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009019616A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102603520A (en) * | 2012-03-23 | 2012-07-25 | 中国药科大学 | Method for preparing 1H-indene-1-ketone-3-methanoic acid compound |
-
2008
- 2008-08-08 WO PCT/IB2008/003117 patent/WO2009019616A2/en active Application Filing
Non-Patent Citations (5)
Also Published As
Publication number | Publication date |
---|---|
WO2009019616A2 (en) | 2009-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007090393A3 (en) | Microtablet-based pharmaceutical preparation | |
WO2006114520A3 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
EP4220163A3 (en) | New colors for chromogenic ihc and ish staining with multi-dye quinone methide and tyramide conjugates | |
IL213920A0 (en) | 3,3'-spiroindolinone derivatives as anticancer agents | |
AP2384A (en) | 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
WO2008017346A3 (en) | Ascorbic acid derivatives, use thereof for the functionalization of matrices | |
HK1154868A1 (en) | Cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method -4--3- | |
WO2011009938A3 (en) | Stambomycin and derivatives, their production and their use as drugs | |
ATE519373T1 (en) | TEA COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | |
WO2011157722A3 (en) | Solid ivabradine-containing composition | |
WO2009051460A3 (en) | Peptide coupled ascorbic acid derivatives | |
WO2011122872A3 (en) | Composition comprising coumestrol or a bean extract containing coumestrol | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
WO2009051417A3 (en) | Phenanthrene lactam derivatives having anticancer activity and method for the preparation thereof | |
WO2013143792A3 (en) | Dry shampoo composition | |
WO2010046926A3 (en) | Novel stilbene analogs | |
WO2007083190A3 (en) | Water insoluble helichrysum extract, process for preparing the same and uses thereof | |
WO2008034912A3 (en) | Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof | |
WO2011021864A3 (en) | Novel compound for complementing anticancer drugs, a production method for the same, a composition for complementing anticancer drugs comprising the same, and a method for reducing resistance to anticancer drugs using the same | |
WO2009019616A3 (en) | Isoprekinamycin analogs and syntheses thereof | |
WO2008149244A3 (en) | Compositions and methods comprising analogues of radicicol a | |
WO2004069145A3 (en) | Anticancer compounds, process for their preparation and pharmaceutical compositions containing them | |
WO2012021409A3 (en) | Anthraquinone Analogs | |
WO2011156045A3 (en) | Tablet formulation of ezatiostat | |
WO2009049961A3 (en) | New no-donor aspirin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08827074 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08827074 Country of ref document: EP Kind code of ref document: A2 |